Course1

Advanced Life Sciences Institute - Carving Out Induced Infringement: Strategy for Skinny Labels

  • Author/Instructor:  BCLT

BCLT’s new Life Sciences Project is thrilled to announce the launch of our Advanced Life Sciences Institute. We are very excited to be kicking this new program off on April 22, 2022, with a conference on IP and licensing. Join us for in-depth discussions and examination of key issues related to intellectual property and transactions in the life sciences sector. Learn from the life sciences legal experts! CLE will be offered. Speakers: Kira Davis, Durie TangriAzra Hadzimehmedovic, TensegrityRyan Johnson, Fenwick    

Course1

Advanced Life Sciences Institute - Facilitating Collaboration in the Life Sciences – Funding, Licensing, and International Collaboration

  • Author/Instructor:  BCLT

BCLT’s new Life Sciences Project is thrilled to announce the launch of our Advanced Life Sciences Institute. We are very excited to be kicking this new program off on April 22, 2022, with a conference on IP and licensing. Join us for in-depth discussions and examination of key issues related to intellectual property and transactions in the life sciences sector. Learn from the life sciences legal experts! CLE will be offered. Speakers: Kate Hillier, Cooley Ryan Murr, Gibson Dunn Margaret Sampson, Baker Botts    

Course1

Advanced Life Sciences Institute - Protecting and Licensing AI Inventions in the Life Sciences

  • Author/Instructor:  BCLT

BCLT’s new Life Sciences Project is thrilled to announce the launch of our Advanced Life Sciences Institute. We are very excited to be kicking this new program off on April 22, 2022, with a conference on IP and licensing. Join us for in-depth discussions and examination of key issues related to intellectual property and transactions in the life sciences sector. Learn from the life sciences legal experts! CLE will be offered. Speakers: Hogene Choi, Morrison & Foerster Hans Sauer, BIO Bruce Wexler, Paul Hastings Andrew Whitehead, Genentech

Course1

Advanced Life Sciences Institute - Protecting IP and Litigating into Uncertainty: Challenges from Sections 101 and 112 in the Life (...)

  • Author/Instructor:  BCLT

Advanced Life Sciences Institute - Protecting IP and Litigating into Uncertainty: Challenges from Sections 101 and 112 in the Life Sciences BCLT’s new Life Sciences Project is thrilled to announce the launch of our Advanced Life Sciences Institute. We are very excited to be kicking this new program off on April 22, 2022, with a conference on IP and licensing. Join us for in-depth discussions and examination of key issues related to intellectual property and transactions in the life sciences sector. Learn from the life sciences legal experts! CLE will be offered. Speakers: Natalie Derzko, Covington & Burling Colleen Tracy James, White & Case Eugene Novikov, Durie Tangri Richard Torczon, Wilson Sonsini  

Course1

Advanced Life Sciences Institute - The Judicial Perspective

  • Author/Instructor:  BCLT

BCLT’s new Life Sciences Project is thrilled to announce the launch of our Advanced Life Sciences Institute. We are very excited to be kicking this new program off on April 22, 2022, with a conference on IP and licensing. Join us for in-depth discussions and examination of key issues related to intellectual property and transactions in the life sciences sector. Learn from the life sciences legal experts! CLE will be offered. Speakers: Jeremy Fogel, Berkeley Law / Berkeley Judicial Institute (moderator)Judge Stanley Chesler, District of New JerseyJudge Beth Freeman, Northern District of CaliforniaJudge Kathleen O’Malley, U.S. Court of Appeals, Fed. Cir. (ret)Judge Leonard Stark, U.S. Court of Appeals, Fed. Cir.  

Course1

BTLJ-CMTL-BCLT Symposium | Race & Technology Law: Innovating Health Equity

  • Author/Instructor:  BCLT

The nexus of technology and the law has played a major role in amplifying racial injustices in many of society’s institutions. The global COVID-19 pandemic has exacerbated pre-existing racial disparities in medicine, shedding light on the ways in which technology and the law impact equitable access to healthcare. But technology and the law can also be instruments for structural change. As future lawyers, the student leaders of the Berkeley Technology Law Journal (BTLJ) and the Coalition of Minorities in Tech Law (CMTL) are eager to examine race, health equity, and the effects of technological innovation on communities of color. Therefore, we are convening this special symposium with the Berkeley Center for Law and Technology (BCLT). Last fall, the first annual BTLJ-BCLT Race & Technology Law Symposium broached a variety of tech law topics as they intersect with race. This year, the Symposium focuses on how race, technology, and the law intersect in the healthcare space. We have invited leading and rising legal academics to share their research and perspectives on the intersection of technology, law, and race within the American healthcare system. In conversation with one another, they will help us explore and propose options for anti-racist paths forward for the fields of technology law and healthcare. We have entitled this symposium: “Race & Technology Law: Innovating Health Equity.” Our panels will highlight a variety of tech law topics as they intersect with race and healthcare. A few of these topics include: -Access to healthcare innovation -Telehealth medicine -Reproductive rights -Eugenics and CRISPR-Cas9 technology Speakers: Sharona Hoffman, Edgar A. Hahn Professor of LawCarol McCall, Chief Health Analytics Officer at ClosedLoop.aiChristopher Morten, Columbia Law SchoolFabiola Carrión, National Health Law ProgramPeyten Sharp, Akin GumpDayna Bowen Matthew, George Washington University Law SchoolJohn Evans, Institute for Practical Ethics at University of California, San DiegoPeter Groeneveld, University of Pennsylvania’s Perelman School of MedicineOsagie K. Obasogie, University of CaliforniaTahir Amin, I-MAKWendy Epstein, DePaul College of LawJimmy Sanders, Gunderson Dettmer  

Course1

China Stakes Out Its Place in Plant Variety Protection: An Update with Experts on PVP and Agricultural IP Developments (...)

  • Author/Instructor:  BCLT

China Stakes Out Its Place in Plant Variety Protection: An Update with Experts on PVP and Agricultural IP Developments in China Article 14 Any plant variety in respect of which variety rights are granted shall have the characteristic of novelty. Novelty means that the propagating material of the new plant variety in respect of which variety rights are applied for has not been sold prior to the filing date of the application, or has not been for sale, with the consent of the breeder, for more than one year within the territory of China; the propagating material of vines, forest trees, fruit trees and ornamental plants must not have been for sale for more than six years, or the propagating material of other plant varieties for more than four years, in a foreign territory. As always please consult counsel for specific legal advice. Since China established its legal regime for the protection of new varieties of plants in 1997, it has emerged as the country with the largest number of plant variety applications in the world, as well as the most litigious.  China’s current plant variety regime focuses on policy and legislative initiatives, including work on a new Seed Law by the National People’s Congress. Its plant variety protection enforcement efforts also reflect many of the reforms already undertaken in other areas of IP law, including: providing for punitive damages, burden of proof reversals and exceptions and limitations to infringement. Yet, China has yet to accede to UPOV ’91, the latest version of the WIPO treaty to protect plant varieties.  To what extent does China’s plant variety IP regime address China’s twin goals of becoming an agricultural innovator and meeting the food security needs of its vast population? We will explore the public policy implications of China’s efforts to become a major force in new plant varieties, the technical aspects of China’s emerging plant variety regime, and how these changes fit into China’s overall IP practice. Speakers Elaine Wu, USPTOAmy Martin, Driscoll’sDan Fang, American Seed Trade AssociationXu Yi, Lusheng Law FirmZhou Yanhao, Sinochem/SyngentaAlanna Rennie, Baker McKenzieMark A Cohen, BCLT/Berkeley LawMichael Ward, Morrison Foerster